65 results
Page 2 of 4
8-K
EX-99.1
kflg2i9q
1 Aug 22
Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name
9:17am
S-8
EX-99.1
eax 1l6tglppiv
20 May 22
Registration of securities for employees
4:06pm
424B5
mmx63gqplttdf 3jn9if
19 May 22
Prospectus supplement for primary offering
4:44pm
8-K
EX-2.1
p6iuvp s56gd8wuk9txh
12 May 22
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-99.1
zej5x ub7x8da
10 May 22
Cortexyme Announces Agreement to Acquire Novosteo
8:08am
8-K
2leiosbam9v
10 May 22
Cortexyme Announces Agreement to Acquire Novosteo
8:08am
POS AM
9e6v3e
4 Mar 22
Prospectus update (post-effective amendment)
4:04pm
POSASR
faoo73r7naey4eqenla
7 Feb 22
Automatic shelf registration (post-effective amendment)
5:01pm
8-K
mk59v
2 Feb 22
Results of Operations and Financial Condition
5:02pm
8-K
mmracoreuuf1ot
26 Jan 22
Other Events
8:15am
424B5
tb3h9tkbl6605g6dehd
23 Dec 21
Prospectus supplement for primary offering
5:24pm
8-K
ais oowkux0
26 Oct 21
Other Events
4:11pm